Trending

Gedeon Richter

Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe

Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe

Two biosimilars of Eli Lilly’s blockbuster osteoporosis treatment Forsteo – from Hungary’s Gedeon Richter and German partner Stada

X

Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe

https://pharmaphorum.com/news/lilly-faces-biosimilar-rivals-to-osteoporosis-drug-forsteo-in-europe/

Allergan and Gedeon Richter set to expand use of bipolar drug

Allergan and Gedeon Richter set to expand use of bipolar drug

Companies want Vraylar as option bipolar depression

X

Allergan and Gedeon Richter set to expand use of bipolar drug

https://pharmaphorum.com/news/allergangedeon-richter-aim-expand-use-bipolar-drug/

Drug price controversies hit pharma’s reputation

Drug price controversies hit pharma’s reputation

Patient groups slam pharma over drug costs in latest survey.

X

Drug price controversies hit pharma’s reputation

https://pharmaphorum.com/news/drug-price-pharma-reputation/

Allergan/Gedeon Richter’s uterine fibroids drug succeeds in Phase 3

Allergan/Gedeon Richter’s uterine fibroids drug succeeds in Phase 3

Allergan and Gedeon Richter’s uterine fibroid treatment ulipristal acetate, has succeeded in a phase 3 trial ahead of

X

Allergan/Gedeon Richter’s uterine fibroids drug succeeds in Phase 3

https://pharmaphorum.com/news/allergan-gedeon-richters-uterine-fibroids-drug-succeeds-in-phase-3/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com